Stockreport

Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target [Yahoo! Finance]

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) from $2.50 to $6.00 and left the Hold rating unchanged. This decision came after Zentalis said it had selected the optimal dos [Read more]